Concepedia

Author

Nikita Makretsov

University of British Columbia

Also Known As

N A Makretsov, N Makretsov, N. A. Makretsov, N. Makretsov, Nikita A Makretsov, Nikita A. Makretsov, Nikita Makretsov

28

Publications

1.8K

Citations

14

H-Index

23

Concepts

All Affiliations

University of British ColumbiaVancouver General HospitalBC Cancer AgencyStanford UniversityMemorial University of Newfoundland
NM

About

Nikita Makretsov is an author at University of British Columbia specializing in medicine, pathology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

605

2

Cell Biology

4

4

380

3

Engineering

1

1

65

4

Biostatistics

1

1

63

5

Endocrinology

1

1

117

Nikita Makretsov

×

15

Publications

1.7K

Citations

14

H-Index

YearCitations

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Sarah‐Jane Dawson, Nikita Makretsov, Fiona M. Blows,

British Journal of Cancer

2010

323

Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma

Nikita Makretsov, David G. Huntsman, Torsten O. Nielsen,

Clinical Cancer Research

2004

203

Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression

Aruna M. Somasiri, Julie S. Nielsen, Nikita Makretsov,

Cancer Research

2004

153

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis

Shahriar Dabiri, David G. Huntsman, Nikita Makretsov,

Modern Pathology

2004

149

Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.

Derek L. Dai, Nikita Makretsov, Eric I. Campos,

PubMed

2003

130

A fluorescence in situ hybridization study of <i>ETV6‐NTRK3</i> fusion gene in secretory breast carcinoma

Nikita Makretsov, May He, Malcolm Hayes,

Genes Chromosomes and Cancer

2004

124

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer

Nikita Makretsov, C. Blake Gilks, Andrew J. Coldman,

Human Pathology

2003

117

Coexpression of the type 1 growth factor receptor family members HER‐1, HER‐2, and HER‐3 has a synergistic negative prognostic effect on breast carcinoma survival

Sam M. Wiseman, Nikita Makretsov, Torsten O. Nielsen,

Cancer

2005

107

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade

Nikita Makretsov, Malcolm Hayes, Beverley A. Carter,

Modern Pathology

2006

97

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas

Lindsay Brown, Julie Irving, Robin Parker,

Gynecologic Oncology

2005

84

Page 1